Aspen Aerogels (ASPN) Reports Q1 Loss, Lags Revenue Estimates

Group 1 - Aspen Aerogels reported a quarterly loss of $0.06 per share, better than the Zacks Consensus Estimate of a loss of $0.07, and compared to earnings of $0.01 per share a year ago, representing an earnings surprise of 14.29% [1] - The company posted revenues of $78.72 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 5.08%, and down from year-ago revenues of $94.5 million [2] - Aspen Aerogels shares have declined approximately 52.1% since the beginning of the year, contrasting with the S&P 500's decline of 4.3% [3] Group 2 - The earnings outlook for Aspen Aerogels is mixed, with the current consensus EPS estimate for the coming quarter at $0.02 on revenues of $89.53 million, and $0.13 on revenues of $395.71 million for the current fiscal year [7] - The Zacks Industry Rank for Building Products - Miscellaneous is currently in the top 38% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8] Group 3 - The estimate revisions trend for Aspen Aerogels is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]